HopeStage
Back to all studies
CompletedNCT03955549

Insight Skills or Metacognitive Training for Schizophrenia

About this titleRead the official source — NCT03955549
Medication studyAges 18–65Egypt
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
ŢalkhāSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: May 1, 2019
Recruitment status
Completed
Enrollment listed in the registry
99
Sponsor
Agiad Psychiatry Hospital
Sponsor type
Hospital / academic medical center
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Egypt
Age range
From 18 Years to 65 Years
Official registry ID
NCT03955549
Official title
Show the full official title

Insight Enhancement Program vs. Metacognitive Training for Psychosis in Patients With Schizophrenia: A Three-Armed Comparative Randomized Controlled Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Ţalkhā

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Agiad Psychiatry Hospital, a hospital or academic medical center.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies